CD19 and Miyoshi myopathy: Although CD19 is not an ideal antigen in multiple myeloma (MM), for its low expression in MM [53], Garfall et al. still reported that CAR-T cell therapy in conjunction with autologous transplantation has achieved durable CR in a patient with advanced MM [54].